Anti-Painkiller Abuse Bill Might Inflate Cost Of Generics

Law360, New York (July 19, 2012, 8:57 PM EDT) -- A bipartisan bill introduced Thursday to require drug companies to make prescription painkillers tamper-resistant, part of a recent push to curtail abuse of the drugs, could drive up the cost of generic drugs by forcing generics makers to license anti-tampering intellectual property or develop their own, experts say.

The Stop Tampering of Prescription Pills Act of 2012, or STOPP Act, introduced by Reps. Bill Keating, D-Mass., and Mary Bono Mack, R-Calif., would mandate that drugmakers manufacture opioids to be resistant to crushing or otherwise made more...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.